Skip to content

Engager: Evaluation of a collaborative care intervention for offenders

Evaluation of a complex intervention (Engager) for prisoners with common mental health problems, near to and after release -­ Full Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN11707331
Enrollment
280
Registered
2016-02-04
Start date
2016-01-14
Completion date
Unknown
Last updated
2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Mental Health

Interventions

In the first phase of this study, a collaborative care intervention (Engager intervention) for prisoners with common mental health problems, near to and after release was developed. This study will lo

Sponsors

Devon Partnership NHS Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Men with prison sentence of two years or less 2. Have between 20 and 4 weeks remaining to serve 3. Be identified using screening instruments as having, or likely to have following release, common mental health problems (e.g. depression, anxiety, PTSD) 4. Be willing to engage with treatment services and research procedures 5. Released to the geographical area of the study

Exclusion criteria

Exclusion criteria: 1. Prisoners on remand 2. Women (numbers are smaller and resettlement needs are different; research procedures developed are not feasible for this context) 3. Have a serious and enduring mental disorder and/or under the prison in-reach team 4. Those with active suicidal intent requiring management under the safer custody process or prison in-reach team, and where the healthcare team managing the prisoner feel it would be detrimental NOTE: Once risk levels reduce individuals in this group will be eligible if not excluded for another reason 5. Have a primary personality disorder who are on the caseload of the Offender Personality Disorder Pathway programme 6. Present a serious risk of harm to the researchers or intervention practitioners NOTE: Co-morbid substance misuse and personality disorder are NOT exclusion criteria

Design outcomes

Primary

MeasureTime frame
Psychological distress is measured using the CORE-OM at baseline, 3 and 6 months post release.

Secondary

MeasureTime frame
1. Recidivism based on data from the Police National Computer (PNC) at 12 months post release 2. Assessment of subjective met and unmet need is measured using the Camberwell Assessment of Need – Forensic Version (CAN-FOR) - Adapted at baseline, 3 and 6 months post release 3. Change in objective social domains (accommodation, education, employment and benefits) is measured through interviews at baseline, 3 and 6 months post release 4. Service utilisation and helpfulness of services is measured using the Client Service Receipt Inventory (CSRI) - Adapted at baseline, 3 and 6 months post release 5. Health related quality of life… is measured using the EQ-5D-5L at baseline, 3 and 6 months post release 6. Well-being related quality of life is measured using the ICE-CAP-A at baseline, 3 and 6 months post release 7. Experience of care is measured using the Inspire questionnaire (Relationship section only) at baseline, 3 and 6 months post release 8. Drug and alcohol subjective dependence is measured using the Leeds Dependence Questionnaire at baseline, 3 and 6 months post release 9. Participant derived problems is measured using the PSYCHLOPS at baseline, 3 and 6 months post release 10. Hope, trust and motivation is measured using the Intermediate Outcomes Measurement Instrument (IOMI) at baseline, 3 and 6 months post release 11. Drug and alcohol use is measured using the Treatment Outcomes Profile - Adapted at baseline, 3 and 6 months post release

Countries

England, United Kingdom

Contacts

Public ContactTim Kirkpatrick

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 24, 2026